Member Log In

Eurofins Discovery Announces Acquisition of DiscoveryBioMed

5 Jul 2022 3:00 PM | Anonymous member (Administrator)

Eurofins Discovery acquired DiscoveryBioMed for its expertise in leveraging primary and immortalized human diseased and normal cells to develop novel, customized bioassays supporting clients from HTS to lead optimization. DiscoveryBioMed achieves this through its focus on biologically relevant cellular models for the renal, skin, taste, ophthalmic, liver, respiratory, oncology, and other therapeutic areas. The addition of DiscoveryBioMed supports Eurofins Discovery's strategy to have the most complete, highest quality portfolio of drug discovery services and products, and further strengthens its ability to support translational biology for drug discovery research and development.

Read full article here.

Connecting the Bioscience Ecosystem in Alabama

BIO Alabama
100 Drake Dr., Unit 688
Normal, AL 35762

administrator@bioalabama.com

© BIO Alabama

Powered by Wild Apricot Membership Software